Key statistics
On Thursday, Incyte Corp (INCY:DEU) closed at 67.08, -14.57% below its 52-week high of 78.52, set on Nov 11, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 67.68 |
---|---|
High | 67.90 |
Low | 66.48 |
Bid | 66.82 |
Offer | 67.50 |
Previous close | 67.46 |
Average volume | 1.33k |
---|---|
Shares outstanding | 192.65m |
Free float | 188.70m |
P/E (TTM) | 502.97 |
Market cap | 13.56bn USD |
EPS (TTM) | 0.14 USD |
Data delayed at least 15 minutes, as of Nov 21 2024.
More ▼
Press releases
- Incyte Provides Update on Early Phase MRGPRX2 and MRGPRX4 Programs
- Incyte to Present at Upcoming Investor Conference
- Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Incyte to Present at Upcoming Investor Conferences
- Incyte Reports 2024 Third Quarter Financial Results and Provides Updates on Key Clinical Programs
- Incyte Named One of Top 5 Companies on Science Magazine’s 2024 Top Employers List
- Incyte Furthers Commitment to People Living with Atopic Dermatitis by Sharing Additional Patient Experiences as part of its Moments of Clarity Program
- Incyte to Report Third Quarter Financial Results
- Incyte Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- Multiple Late-Breaking Data Presentations from Incyte’s Dermatology Portfolio will be Featured at the European Academy of Dermatology and Venereology (EADV) 2024 Congress
More ▼